Jianerkang Medical Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr '26 Apr 1, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	4,062	4,594	-	-	-	-
Enterprise Value	3,348	4,284	-	-	-	-
Last Close Price	26.04	29.18	-	-	-	-
PE Ratio	38.46	38.21	-	-	-	-
PS Ratio	4.11	4.39	-	-	-	-
PB Ratio	2.79	3.24	-	-	-	-
P/TBV Ratio	2.90	3.37	-	-	-	-
P/FCF Ratio	50.71	45.32	-	-	-	-
P/OCF Ratio	29.28	32.56	-	-	-	-
EV/Sales Ratio	3.39	4.10	-	-	-	-
EV/EBITDA Ratio	22.97	26.26	-	-	-	-
EV/EBIT Ratio	32.78	35.51	-	-	-	-
EV/FCF Ratio	41.79	42.27	-	-	-	-
Debt / Equity Ratio	0.02	-	-	0.04	0.08	0.15
Debt / EBITDA Ratio	0.15	-	-	0.17	0.38	0.12
Debt / FCF Ratio	0.27	-	-	0.31	2.28	0.19
Net Debt / Equity Ratio	-0.49	-0.51	-0.25	-0.19	-0.08	-0.05
Net Debt / EBITDA Ratio	-4.90	-4.42	-1.35	-0.83	-0.36	-0.04
Net Debt / FCF Ratio	-8.92	-7.12	-3.07	-1.53	-2.17	-0.07
Asset Turnover	0.70	0.77	0.97	1.17	0.94	2.04
Inventory Turnover	4.53	4.85	4.88	5.07	3.64	6.27
Quick Ratio	6.98	7.04	2.84	1.83	1.39	0.79
Current Ratio	8.30	8.43	3.87	2.82	2.34	1.38
Return on Equity (ROE)	8.37%	10.32%	14.60%	22.47%	24.07%	132.90%
Return on Assets (ROA)	4.50%	5.58%	7.36%	9.52%	7.59%	46.15%
Return on Invested Capital (ROIC)	12.62%	15.25%	16.58%	20.92%	17.40%	97.32%
Return on Capital Employed (ROCE)	6.80%	8.30%	13.30%	17.20%	15.20%	111.90%
Earnings Yield	2.54%	2.62%	-	-	-	-
FCF Yield	1.97%	2.21%	-	-	-	-
Dividend Yield	1.04%	0.92%	-	-	-	-
Payout Ratio	40.82%	-	0.56%	1.06%	1.60%	29.49%
Buyback Yield / Dilution	-30.14%	-4.97%	-0.21%	0.01%	-12.43%	-9.21%
Total Shareholder Return	-29.11%	-4.04%	-0.21%	0.01%	-12.43%	-9.21%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.